You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Lymphoid

Showing 1 - 25 of 6,227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Mar 20, 2023

      Chronic Lymphocytic Leukemia Patients

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
        • San Francisco, California
          Power Life Sciences
        Jun 2, 2023

        Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

        Recruiting
        • Non Hodgkin Lymphoma
        • +2 more
        • Fully human anti CD19 CAR-T Cell Dose
        • +2 more
        • Cleveland, Ohio
          University Hospitals Cleveland Medical Center, Case Comprehensiv
        Oct 4, 2022

        Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

        Recruiting
        • Acute Lymphoid Leukemia
        • +3 more
        • São Paulo, SP, Brazil
          Instituto do Cancer do Estado de Sao Paulo
        Jul 24, 2023

        Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

        Active, not recruiting
        • Recurrent Chronic Lymphoid Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Dec 19, 2022

        Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • (no location specified)
        Jul 10, 2023

        Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

        Not yet recruiting
        • Lymphoblastic Leukemia
        • Palo Alto, California
          Stanford University
        Aug 14, 2023

        Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling

        Not yet recruiting
        • Acute Lymphoid Leukemia
        • Acute Myeloid Leukemia in Children
        • Biological sampling in patients
        • Biological sampling in control patients
        • Tours, France
        • +2 more
        Mar 17, 2023

        Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

        Active, not recruiting
        • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
        • +2 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jan 20, 2023

        Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)

        Completed
        • Acute,Leukemia, Lymphoid
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Aug 2, 2022

        Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

        Not yet recruiting
        • Breast Cancer
        • +9 more
        • Assessment tool IA3-CP with SDoH
        • Assessment tool IA3-CP without SDoH
        • (no location specified)
        May 22, 2023

        Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

        Completed
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Myeloma Coach or CLL Coach Mobile App
        • Springboard Beyond Cancer informational website
        • Durham, North Carolina
          Duke University
        Jun 23, 2023

        Biomarker for Infection Risk in CLL and MM

        Not yet recruiting
        • Multiple Myeloma
        • Chronic Lymphocytic Leukemia
        • Screening
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        May 3, 2023

        Enteral Nutrition in Children Treated for Acute Lymphoblastic

        Active, not recruiting
        • Leukemia, Lymphoblastic
        • enteral or parenteral nutritional support
        • Vandœuvre-lès-Nancy, France
          CHRU Nancy
        Oct 26, 2023

        Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

        Not yet recruiting
        • Pediatric Acute Lymphoblastic Leukemia
        • +2 more
        • Sleep ALL Night
        • Boston, Massachusetts
        • +1 more
        May 10, 2023

        Lymphoid Leukemia, Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Tampa (CPX-351)

        Active, not recruiting
        Has Results
        • Lymphoid Leukemia
        • +3 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Dec 30, 2022

        ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

        Not yet recruiting
        • ALL, Childhood B-Cell
        • +2 more
        • Tafasitamab
        • (no location specified)
        Nov 25, 2022

        Understanding Chronic Lymphocytic Leukemia

        Recruiting
        • Chronic Lymphocytic Leukemia
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          Aug 1, 2022

          B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

          Active, not recruiting
          • B-Lymphoid Malignancies
          • +3 more
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Aug 1, 2022

          Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

          Not yet recruiting
          • Leukemia, Lymphocytic, Chronic, B-Cell
          • Small Lymphocytic Lymphoma
          • (no location specified)
          Jul 19, 2023